✦ LIBER ✦

Pharmacologic and Pharmacokinetic Profile of Mibefradil, a T- and L-type Calcium Channel Antagonist

✍ Scribed by Darrell R Abernethy; MD; PhD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of Mibefradil, a New Once-a-Day,

✍ Isaac Kobrin; MD; Vincent Charlon; PhD; Elisabeth Lindberg; MD; Robert Pordy; MD 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Mibefradil, a T-Type and L-Type Calcium

✍ Michaela M. Mocanu; Shashi Gadgil; Derek M. Yellon; Gary F. Baxter 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 192 KB

Effect of mibefradil, a T-type calcium-c

✍ Ishikawa Kimito; Ohtsuka Sadanori; Yamaguchi Iwao 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The antihyperalgesic effects of the T-ty

✍ Matthew E. Barton; Elizabeth L. Eberle; Harlan E. Shannon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Human vascular to cardiac tissue selecti

✍ Doreen Sarsero; Toshimasa Fujiwara; Peter Molenaar; James A Angus 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 358 KB

Mechanical and thermal antinociception i

✍ Slobodan M Todorovic; Adam Meyenburg; Vesna Jevtovic-Todorovic 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 344 KB